Number

Title

Date

1

[Press Release] ToolGen Receives Intention to Grant for European ‘CRISPR RNP’ Patent… Vertex’s Attempt to Block Overturned

2025.12.10

2

[Press Release] ToolGen Successfully Defends European CRISPR RNP Plant Patent… “An Unprecedented Outcome Overturning Preliminary Decision”

2025.12.03

3

[Press Release] ToolGen and GenEditBio Sign Strategic Cross-License Agreement… Accelerating Co-Development of Innovative Gene-Editing Therapies

2025.11.24

4

[Overseas Press Release ] ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

2025.11.24

5

[Press Release] ToolGen Completes U.S. Patent Registration for CRISPR Cas9 RNP Core Technology… Files U.S. Lawsuit Related to CASGEVY®

2025.11.19

6

[Overseas Press Release] ToolGen Completes U.S. Patent Registration for Core CRISPR Cas9 RNP Technology; Files U.S. Lawsuit Related to CASGEVY®

2025.11.19

7

[Notice] U.S. Patent Registration Certificate (CRISPR RNP)

2025.11.18

8

[Press Release] ToolGen Signs CRISPR-Cas9 Technology Transfer Agreement with Abinogen

2025.11.06

9

[The Bio] CRISPR-Cas9 Foundational Patent Invalidated in China’s First Trial—CVC Group Loses… ToolGen Smiles

2025.09.30

10

[Press Release] ToolGen Selected for ‘Korean ARPA-H’ Project… Developing Gene-Editing Therapy for Rare Hereditary Retinal Diseases in Korea and Japan

2025.09.10

11

[Press Release] ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands

2025.09.08

12

[Overseas Press Release] ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands

2025.09.08

13

[Hankyung BIO Insight] ToolGen, Holder of CRISPR-Cas9 Foundational Patent, Targets Therapeutics and Seeds with Technological Edge

2025.08.19

14

[Press Release] ToolGen and Farmirace Receive Agricultural Food New Technology (NET) Certification for ‘Virus-Based Pepper Gene-Editing Technology’

2025.08.13

15

[Press Release] KBIOHealth Signs MOU with ToolGen for Collaborative Research in Drug Development

2025.08.12